Jeffrey Horowitz, MD

Physician, Professor

Pulmonary Disease, Critical Care Medicine

Make an appointment

614-293-4925
Accepting new patients

Conditions and expertise

  • Chronic Bronchitis
  • Pulmonary Fibrosis
  • Emphysema
  • Intensive Care
  • Intensive Care Units
  • Lung

View all conditions

Locations

  • Lung Care

View location details

Academics and research

Department: Internal Medicine

View my research

About

Gender
Male

Biography

As a pulmonary and critical care physician, my clinical practice is comprised of general outpatient and inpatient care for patients with acute or chronic lung disease and the care of patients in the medical intensive care units at The Ohio State University Wexner Medical Center. I also have an active research program focused on the cellular and molecular underpinnings of chronic fibrotic lung diseases such as Idiopathic Pulmonary Fibrosis with the long term goal of identifying novel therapeutic targets that will improve the lives of patients. I strive to communicate in a direct, honest and compassionate manner, to complete a thoughtful and reasoned diagnostic assessment and to partner with patients to determine the optimal therapies. Ultimately, my goal is to combine the best medical evidence with each patient’s goals and preferences to personalize the care of each patient.

Outside of work, I enjoy time with my wife and my two daughters. I enjoy sports, especially baseball, football, college basketball and gymnastics. Originally from the west suburbs of Chicago, I am a passionate Cubs and Bears fan. I enjoy exercising regularly, occasional travel, and Star Wars, Avengers, LoTR and GoT.

Highlights

  • Division Director, Division of Pulmonary, Critical Care and Sleep Medicine (2020)
  • Research Funding from National Institutes of Health (2005-current)
  • Fellow of the American Thoracic Society (2018)
  • Editorial Board Member: The American Journal of Respiratory Cell and Molecular Biology (since 2017) and The American Journal of Pathology (since 2009)
  • Deputy Editor (2017-2019), Associate Editor (2016-2017) and Editorial Board Member (2019-present) of Respirology: the Official Journal of the Asian Pacific Respiratory Society
  • Sequence Director, M1 and M2 Respiratory Sequence (physiology and pathophysiology), University of Michigan Medical College (2015-2019)
  • Fellow of the American College of Chest Physicians (2008)
  • T. Franklin Williams Scholar of the Association of Specialty Professors (2008)
  • Recipient of the Dalsemer Award for Research in Interstitial Lung Disease from the American Lung Association (2006)
  • Medical Staff Award for Clinical Excellence, Rush Medical College (1998)
  • Alpha Omega Alpha, Rush Medical College (1998)
  • Phi Beta Kappa, Syracuse University (1993)

Conditions and expertise

  • Asthma
  • Chronic Bronchitis
  • Emphysema
  • Intensive Care
  • Intensive Care Units
  • Interstitial Lung Diseases
  • Lung
  • Lung Diseases
  • Pulmonary Fibrosis
  • Pulmonary Medicine

Locations

Lung Care

in Martha Morehouse Outpatient Care
2050 Kenny Road
Suite 2200
Columbus, OH 43221
614-293-4925

Please note: Not all physicians schedule patients at each listed location.

Credentials

Education

Fellowship - Pulmonary and Critical Care Medicine
University of Michigan Hospitals, Ann Arbor, MI, United States
7/1/2001 - 6/30/2004
Residency - Internal Medicine
Rush University Medical Center, Chicago, IL, United States
7/1/1999 - 6/30/2001
Internship - Internal Medicine
Rush University Medical Center, Chicago, IL, United States
7/1/1998 - 6/30/1999
Doctor of Medicine (MD)
Rush Medical College at Rush University, Chicago, IL, United States
9/1/1994 - 6/1/1998

Certifications

  • American Heart Association National Center
    1/2/2025
  • American Board of Internal Medicine/Pulmonary Disease
    10/8/2013
  • American Board of Internal Medicine/Critical Care Medicine
    11/3/2004
  • American Board of Internal Medicine
    8/21/2001

Academics and research

Mechanistic regulation of fibroblast survival and function by soluble and extracellular-matrix derived signaling during lung injury, repair and resolution, with a focus on how these mechanisms contribute to the pathogenesis of fibrotic lung diseases such as idiopathic pulmonary fibrosis (IPF).

Research interests

  • Fibrotic Lung Diseases
  • Idiopathic Pulmonary Fibrosis (IPF)

Academic information

Department:
Internal Medicine
Division:
Pulmonary, Critical Care and Sleep

More about my research

Ratings and reviews

The overall patient satisfaction rating is an average of all patient responses to the six doctor communication related questions shown below from the Clinician and Group Consumer Assessment of Healthcare Providers and Systems survey. For additional information about the patient satisfaction survey, please visit our Patient Satisfaction Survey page.

The comments are submitted by patients and reflect their view and opinions. The comments are not endorsed by and do not necessarily reflect the views of Ohio State Wexner Medical Center.

39 Patient Satisfaction Reviews

4.7 out of 5 overall
  • Explains Things Carefully
    4.8 / 5
  • Listens Carefully
    4.9 / 5
  • Gives Understandable Instructions
    4.7 / 5
  • Knows My Medical History
    4.8 / 5
  • Shows Respect
    4.9 / 5
  • Time Spent Together
    4.9 / 5

Patient Comments

  • Reviewed on Nov 03, 2025

    My provider is always nice, friendly concerned, and has helped me a lot !

  • Reviewed on Sep 14, 2025

    He didn't give me the feeling that he was invested in my health. It made me aware that he was filling in.

  • Reviewed on Sep 07, 2025

    I had none it was fine

  • Reviewed on Aug 03, 2025

    I am always impressed with Dr. Horowitz. He comes into the room having looked at all my labs and CT scans prior to entering the room. His explanations of my concerns are always easy to understand and he is very kind.

  • Reviewed on Jul 06, 2025

    I had no bad experiences.

Consulting and Related Relationships

At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.

As of 11/3/2025 Dr. Horowitz has reported relationships with the companies or entities listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office.

  • Boehringer Ingelheim
  • Merck Sharp & Dohme
  • Pfizer

Subscribe. Get just the right amount of health and wellness in your inbox.